Affigenix Biosolutions Private Limited is an emerging Bangalore based ISO 9001-2008 certified biotech company. The R & D facility at Bangalore is equipped to do cutting edge research in areas such as antibody engineering, drug delivery, immuno and molecular diagnosis. For the short term, Affigenix is providing custom biosolutions to biopharma companies and has also developed some viable low volume high value products for biosimilar product development, biomarker discovery and personalized medicine. Long term plan is to discover and develop safe, pure and potent biologics to target complex diseases.
Name and contact details of Chairperson/Managing director
MD & CSO
Biochemistry, Cell biology, Molecular biology, Microbiology, discovery
265/1F KSSIDC Industrial Area, Bommasandra, Anekal Taluk, Bangalore, Karnataka, 560103
Affigenix provides complete solutions for bioanalytical, bioassay and clearance assay development for biologics manufacturing.
Affigenix focus on developing the immune, molecular and cell based assay suitable for biologics drug and diagnostics development has enabled us to become a go-to- company for developing highest performing assay with tough and unique specifications from our clients.
With our expertise and experience, we offer right mix of product and services to our clients and when needed we become a reliable resource for seeking advice and guidance on designing preclinical toxicity study and clinical PKPD and immunogenicity studies.
Affigenix leachate and impurity clearance assays are specific, sensitive and highest quality to meet the scientific and regulatory specifications. Typically our customized products would simplify and speed up the biologics manufacturing process optimization and routine batch release testing of drugs for marketing.
We provide customized immunoassay to monitor Trypsin clearance, CpB clearance, Enterokinase clearance as well as single chain precursors of Insulin and Insulin analogues Pro-Insulin, Pro-Aspart, Pro-Glargine and Pro-Lispro . In addition we also develop analogue specific antibodies pAb with less or no cross reactivity to endogenous insulin.
Affigenix also offer fit-for-use cost effective critical reagents specifically developed for the biosimilar development which provides clients an easy–to-develop custom assay that complies with most regulatory requirements.